Included in this edition are:

• New Board Member Appointed (Carolyn Kobernick)
• Staffing Changes
  • Sylvie Dupont’s retirement
  • Guillaume Couillard joins the PMPRB (new Director of the Board Secretariat, Communications and Strategic Planning)
  • Appointments:
    • Tanya Potashnik (Director of the Policy and Economic Analysis Branch)
    • Elena Lungu (Manager of the National Prescription Drug Utilization Information System (NPDUIS))
• Decisions in Cases: ratio-Salbutamol, ratiopharm and Sandoz
• Voluntary Compliance Undertakings (VCUs):
  • Gonal F, EMD Inc.
  • Lamisil, Novartis Pharmaceuticals Canada Inc.
• HDAP Meeting Schedule for 2015 & Filing Requirements:
  • February 9
  • May 4
  • September 14
  • November 30

Patentees who have already filed their product monograph and Form 1 (on or before July 18, 2014) have until August 18, 2014 to file their submissions for HDAP´s last meeting in 2014, to be held on November 10, 2014.

• Other news include:
  • NPDUIS Update – 3 Upcoming Publications
    • Drug Plan Expenditure (PDPEx) Report
    • Drug Prices in Canada: 2013
    • Drug Pipeline Monitor (NDPM) – 6th edition
  • Summary of May 8, 2014 Board Meeting

More details regarding the July 2014 NEWSletter can be found on the PMPRB website.